Lensar LNSR
NASDAQ LNSR
$8.40 -0.32 (-3.67%)
As of: Aug 20, 2026 · 3:59 PM EDT

Lensar (LNSR) Liabilities and Shareholders Equity (2019 - 2026)

Lensar (LNSR) posted quarterly Liabilities and Shareholders Equity of $66.2 million for Q1 2026, down 9.23% year-over-year from $73.0 million in Q1 2025, and down 7.29% quarter-over-quarter from $71.4 million in Q4 2025.

Lensar (LNSR) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Lensar (LNSR) has reported Liabilities and Shareholders Equity for 8 consecutive years, with $66.2 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 9.23% year-over-year to $66.2 million; the TTM figure through Mar 2026 stood at $278.3 million (up 5.93% YoY), while the FY2025 annual figure was $71.4 million, up 7.74% from the prior year.
  • Liabilities and Shareholders Equity declined to $66.2 million in Q1 2026 per LNSR's latest filing, from $71.4 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $73.0 million in Q1 2025 and bottomed at $52.0 million in Q1 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $64.7 million across 5 years, with a median of $66.2 million in 2026.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slipped 19.53% — and 2023, when it rose 29.29%.
  • Lensar's Liabilities and Shareholders Equity stood at $55.8 million in 2022, then advanced by 24.61% to $69.6 million in 2023, then decreased by 4.73% to $66.3 million in 2024, then climbed by 7.74% to $71.4 million in 2025, then retreated by 7.29% to $66.2 million in 2026.
  • Business Quant data shows LNSR's Liabilities and Shareholders Equity at $66.2 million in Q1 2026, $71.4 million in Q4 2025, and $70.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 Lensar 103.79 Mn 90.22 Mn 9.78 Mn 69.56 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 69.56 Mn
Mar 31, 2026 66.22 Mn
Dec 31, 2025 71.43 Mn
Sep 30, 2025 70.20 Mn
Jun 30, 2025 70.41 Mn
Mar 31, 2025 72.96 Mn
Dec 31, 2024 66.30 Mn
Sep 30, 2024 62.02 Mn
Jun 30, 2024 61.41 Mn
Mar 31, 2024 66.13 Mn
Dec 31, 2023 69.59 Mn
Sep 30, 2023 70.85 Mn
Jun 30, 2023 71.20 Mn
Mar 31, 2023 51.96 Mn
Dec 31, 2022 55.84 Mn
Sep 30, 2022 54.80 Mn
Jun 30, 2022 58.70 Mn
Mar 31, 2022 60.30 Mn
Dec 31, 2021 66.47 Mn
Sep 30, 2021 68.10 Mn